May Hill Capital
BMY icon

May Hill Capital’s Bristol-Myers Squibb BMY Stock Holding History

May Hill Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$268K Buy
4,296
+503
+13% +$31.8K 0.05% 201
2026
Q2 		$219K Sell
3,793
-202
-5% -$11.6K 0.05% 235
2026
Q1 		$242K Buy
+3,995
New +$233K 0.06% 194

Other funds holding BMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Independent Franchise Partners
Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

May Hill Capital's BMY Position: Q3 2026 in Review

May Hill Capital increased its Bristol-Myers Squibb (BMY) stake by 13% in Q3 2026, buying an estimated $31.8K and bringing the position to 4,296 shares worth $268K. The position accounts for 0.05% of the portfolio, ranked #201.

May Hill Capital first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • May Hill Capital held 4,296 shares of Bristol-Myers Squibb worth $268K as of Q3 2026.
  • May Hill Capital bought 503 Bristol-Myers Squibb shares in Q3 2026, an estimated $31.8K.
  • Bristol-Myers Squibb made up 0.05% of May Hill Capital's portfolio in Q3 2026, its #201 holding.
  • May Hill Capital first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on May Hill Capital's 13F filing for Q3 2026, filed 3 Nov 2026.